The Delaware Supreme Court rejected the legitimacy of expert testimony linking the heartburn drug Zantac to cancer, in a ...

Delaware's highest court ruled on Thursday that nearly 75,000 patients suing four large drugmakers cannot introduce reports ...

Delaware's Supreme Court sides with drugmakers including GSK (GSK) and Pfizer (PFE), rejecting expert testimony linking ...

Delaware's top court reversed a ruling that allowed expert testimony in Zantac cancer lawsuits, citing improper legal ...

In the latest twist in the ocean of Zantac-related litigation playing out across state courts, drugmakers have notched a key ...

GSK and other drugmakers have filed an appeal of a Delaware court’s decision to allow more than 70,000 Zantac-related lawsuits to go ahead.

GSK said that alongside its appeal to the Delaware Supreme Court, it will also file motions for dismissal on other grounds and, at the same time, will progress to trials of individual cases.

The Delaware Supreme Court rejected the legitimacy of expert testimony linking the heartburn drug Zantac to cancer, in a major win for makers of the product. In a unanimous ruling Thursday, the ...

The Dow Jones Industrial Average climbed on Thursday (July 10) as investors brushed aside concerns over new tariff ...